News Novartis' canakinumab cuts risk for heart attack survivors Novartis to discuss canakinumab results with regulators.
News Sanofi/Regeneron PCSK9 lowers cholesterol in diabetes patien... Companies awaiting CV outcomes trial, and court decision in patent case
News Pfizer and Merck's diabetes contender looks to challenge Jar... Merck and Pfizer have Boehringer and Lilly in their sights with ertugliflozin
News Gene therapy for hearts gets FDA fast track Angionetics claims place among leaders in cardiovascular angiogenic gene therapy.
News Lilly/Boehringer diabetes combos get cardio data boost Lilly/Boehringer gain further advantage in US diabetes market.
News CDC panel votes to scrap hepatitis B birth dose advice CDC advisers vote to overturn decades of US policy and abandon endorsement of universal hepatitis B vaccination for newborns in the US.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
